These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26644389)

  • 1. N-Alkyl-, 1-C-Alkyl-, and 5-C-Alkyl-1,5-dideoxy-1,5-imino-(L)-ribitols as Galactosidase Inhibitors.
    Front S; Gallienne E; Charollais-Thoenig J; Demotz S; Martin OR
    ChemMedChem; 2016 Jan; 11(1):133-41. PubMed ID: 26644389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and
    Weber P; Thonhofer M; Averill S; Davies GJ; Santana AG; Müller P; Nasseri SA; Offen WA; Pabst BM; Paschke E; Schalli M; Torvisco A; Tschernutter M; Tysoe C; Windischhofer W; Withers SG; Wolfsgruber A; Wrodnigg TM; Stütz AE
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
    Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
    Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease.
    Thonhofer M; Gonzalez Santana A; Fischer R; Torvisco Gomez A; Saf R; Schalli M; Stütz AE; Withers SG
    Carbohydr Res; 2016 Feb; 420():6-12. PubMed ID: 26717544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomolar β-glucosidase and β-galactosidase inhibition by enantiomeric α-1-C-alkyl-1,4-dideoxy-1,4-imino-arabinitol derivatives.
    Zi D; Song YY; Lu TT; Kise M; Kato A; Wang JZ; Jia YM; Li YX; Fleet GWJ; Yu CY
    Eur J Med Chem; 2023 Feb; 247():115056. PubMed ID: 36603505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase.
    Thonhofer M; Weber P; Santana AG; Fischer R; Pabst BM; Paschke E; Schalli M; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1438-42. PubMed ID: 26838810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
    Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
    J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iminosugar-based galactoside mimics as inhibitors of galactocerebrosidase: SAR studies and comparison with other lysosomal galactosidases.
    Biela-Banaś A; Oulaïdi F; Front S; Gallienne E; Ikeda-Obatake K; Asano N; Wenger DA; Martin OR
    ChemMedChem; 2014 Dec; 9(12):2647-52. PubMed ID: 25377381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitors.
    Lebl R; Thonhofer M; Tysoe C; Pabst BM; Schalli M; Weber P; Paschke E; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Carbohydr Res; 2017 Apr; 442():31-40. PubMed ID: 28288345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.
    Front S; Almeida S; Zoete V; Charollais-Thoenig J; Gallienne E; Marmy C; Pilloud V; Marti R; Wood T; Martin OR; Demotz S
    Bioorg Med Chem; 2018 Nov; 26(20):5462-5469. PubMed ID: 30270003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible synthesis and biological evaluation of novel 5-deoxyadenophorine analogues.
    Pearson MS; Saad RO; Dintinger T; Amri H; Mathé-Allainmat M; Lebreton J
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3262-7. PubMed ID: 16603357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.
    Goeminne A; Berg M; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
    Bioorg Med Chem; 2008 Jul; 16(14):6752-63. PubMed ID: 18571422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G
    Schalli M; Tysoe C; Fischer R; Pabst BM; Thonhofer M; Paschke E; Rappitsch T; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Carbohydr Res; 2017 Apr; 443-444():15-22. PubMed ID: 28319682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new type of pharmacological chaperone for G
    Schalli M; Weber P; Tysoe C; Pabst BM; Thonhofer M; Paschke E; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3431-3435. PubMed ID: 28600215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Guanidino Derivatives of 1,5-Dideoxy-1,5-imino-d-xylitol are Potent, Selective, and Stable Inhibitors of β-Glucocerebrosidase.
    Sevšek A; Šrot L; Rihter J; Čelan M; van Ufford LQ; Moret EE; Martin NI; Pieters RJ
    ChemMedChem; 2017 Apr; 12(7):483-486. PubMed ID: 28328014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
    Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
    Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of D- and L-1-deoxyazasugars.
    Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
    J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CuAAC click chemistry with N-propargyl 1,5-dideoxy-1,5-imino-D-gulitol and N-propargyl 1,6-dideoxy-1,6-imino-D-mannitol provides access to triazole-linked piperidine and azepane pseudo-disaccharide iminosugars displaying glycosidase inhibitory properties.
    Zamoner LO; Aragão-Leoneti V; Mantoani SP; Rugen MD; Nepogodiev SA; Field RA; Carvalho I
    Carbohydr Res; 2016 Jun; 429():29-37. PubMed ID: 27160849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosidase inhibitors from the roots of Glyphaea brevis.
    Gossan DP; Alabdul Magid A; Kouassi-Yao PA; Behr JB; Ahibo AC; Djakouré LA; Harakat D; Voutquenne-Nazabadioko L
    Phytochemistry; 2015 Jan; 109():76-83. PubMed ID: 25468536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
    Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.